SCHEMBL20907232

SCHEMBL20907232

Cc1cc2c(cc1C)C(=O)CC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.38
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
NQO1 P15559 3/20 0.35
POR P16435 3/20 0.35
IMPDH2 P12268 1/20 0.34
IMPDH1 P20839 1/20 0.34
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
ATM Q13315 1/20 0.32
MAPT P10636 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3436882 0.83 GPR3 (0.36)
SCHEMBL14453945 0.81 ALDH1A1 (0.33) HTTKMT2AKDM4EALDH1A1HPGD
SCHEMBL26882708 0.79 TYMS (0.39) HTTMEN1KMT2AKDM4EALDH1A1
SCHEMBL9724230 0.78 MAPK1 (0.33) HTTKMT2A
SCHEMBL26049777 0.78 MAPT (0.36) KMT2AMAPT
SCHEMBL14453946 0.75 ALDH1A1 (0.36) HTTMEN1KMT2AKDM4EALDH1A1
SCHEMBL24396447 0.73 GAA (0.35) HTTMEN1KMT2AKDM4EALDH1A1
SCHEMBL21795579 0.73 EGFR (0.35) IMPDH2IMPDH1MEN1KMT2AKDM4E
SCHEMBL12905443 0.71 BCL2 (0.33)
SCHEMBL3420118 0.71 NQO1 (0.50) HTTGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580254-A A-D-A1-D-A organic small molecule based on triphendioxazine, preparation method and application 大连理工大学 2024-09-03 CN disclosed
WO-2023210772-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND 富士フイルム株式会社 2023-11-02 WO disclosed
US-20190115545-A1 ORGANIC COMPOUND, AND PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE USING THE ORGANIC COMPOUND CANON KABUSHIKI KAISHA (JP) 2019-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190115545-A1 ORGANIC COMPOUND, AND PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE USING THE ORGANIC COMPOUND NR2E1, NR2E3, POU2F1 HTT 3382/4885GRIN2D 1332/4885GRIN3B 3227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.